| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Eli Lilly (NYSE:LLY) is set to give its latest quarterly earnings report on Thursday, 2025-10-30. Here's what investors need to know before the announcement.
Analysts estimate that Eli Lilly will report an earnings per share (EPS) of $5.96.
The market awaits Eli Lilly's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
In the previous earnings release, the company beat EPS by $0.71, leading to a 2.37% drop in the share price the following trading session.
Here's a look at Eli Lilly's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 5.60 | 3.02 | 5.08 | 1.45 |
| EPS Actual | 6.31 | 3.34 | 5.32 | 1.18 |
| Price Change % | -2.00 | 4.00 | 1.00 | -2.00 |
Shares of Eli Lilly were trading at $820.1 as of October 28. Over the last 52-week period, shares are down 0.95%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Eli Lilly visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LLY
